124 related articles for article (PubMed ID: 17372016)
1. IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses.
Ahmed CM; Martin JP; Johnson HM
J Immunol; 2007 Apr; 178(7):4576-83. PubMed ID: 17372016
[TBL] [Abstract][Full Text] [Related]
2. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.
Ahmed CM; Burkhart MA; Subramaniam PS; Mujtaba MG; Johnson HM
J Virol; 2005 May; 79(9):5632-9. PubMed ID: 15827178
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection.
Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2014 Aug; 21(8):1178-84. PubMed ID: 24964806
[TBL] [Abstract][Full Text] [Related]
4. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
5. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.
Liu G; Zhai Q; Schaffner DJ; Wu A; Yohannes A; Robinson TM; Maland M; Wells J; Voss TG; Bailey C; Alibek K
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):201-6. PubMed ID: 15039095
[TBL] [Abstract][Full Text] [Related]
6. The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95-133) prevents encephalomyocarditis virus infection both in tissue culture and in mice.
Mujtaba MG; Patel CB; Patel RA; Flowers LO; Burkhart MA; Waiboci LW; Martin J; Haider MI; Ahmed CM; Johnson HM
Clin Vaccine Immunol; 2006 Aug; 13(8):944-52. PubMed ID: 16893996
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.
Ahmed CM; Dabelic R; Martin JP; Jager LD; Haider SM; Johnson HM
J Immunol; 2010 Jul; 185(2):1103-13. PubMed ID: 20543109
[TBL] [Abstract][Full Text] [Related]
8. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.
Ahmed CM; Dabelic R; Waiboci LW; Jager LD; Heron LL; Johnson HM
J Virol; 2009 Feb; 83(3):1402-15. PubMed ID: 19019946
[TBL] [Abstract][Full Text] [Related]
9. A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.
Symons JA; Tscharke DC; Price N; Smith GL
J Gen Virol; 2002 Aug; 83(Pt 8):1953-1964. PubMed ID: 12124459
[TBL] [Abstract][Full Text] [Related]
10. Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus.
Zaitseva M; McCullough KT; Cruz S; Thomas A; Diaz CG; Keilholz L; Grossi IM; Trost LC; Golding H
J Virol; 2015 Mar; 89(6):3295-307. PubMed ID: 25589648
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity.
Alcamí A; Smith GL
J Virol; 1995 Aug; 69(8):4633-9. PubMed ID: 7609027
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.
Verardi PH; Jones LA; Aziz FH; Ahmad S; Yilma TD
J Virol; 2001 Jan; 75(1):11-8. PubMed ID: 11119568
[TBL] [Abstract][Full Text] [Related]
13. Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections.
Ahmed CM; Johnson HM
J Interferon Cytokine Res; 2014 Oct; 34(10):802-9. PubMed ID: 24811478
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the
Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
[TBL] [Abstract][Full Text] [Related]
15. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.
van Den Broek M; Bachmann MF; Köhler G; Barner M; Escher R; Zinkernagel R; Kopf M
J Immunol; 2000 Jan; 164(1):371-8. PubMed ID: 10605032
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
[TBL] [Abstract][Full Text] [Related]
17. Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201).
Smee DF; Wong MH; Russell A; Ennis J; Turner JD
PLoS One; 2011; 6(10):e26330. PubMed ID: 22022603
[TBL] [Abstract][Full Text] [Related]
18. Gamma interferon signaling: insights to development of interferon mimetics.
Johnson HM; Ahmed CM
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):71-6. PubMed ID: 16914098
[TBL] [Abstract][Full Text] [Related]
19. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
[TBL] [Abstract][Full Text] [Related]
20. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
